491 related articles for article (PubMed ID: 16399633)
1. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
2. The constitutively active Ah receptor (CA-Ahr) mouse as a potential model for dioxin exposure--effects in vital organs.
Brunnberg S; Andersson P; Lindstam M; Paulson I; Poellinger L; Hanberg A
Toxicology; 2006 Jul; 224(3):191-201. PubMed ID: 16766111
[TBL] [Abstract][Full Text] [Related]
3. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
Cheng J; Liu C; Yang P; Zhou T; Mountz JD
J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
[TBL] [Abstract][Full Text] [Related]
4. The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis.
Park KT; Mitchell KA; Huang G; Elferink CJ
Mol Pharmacol; 2005 Mar; 67(3):612-22. PubMed ID: 15550680
[TBL] [Abstract][Full Text] [Related]
5. Fas receptor signaling is requisite for B cell differentiation.
Pasqualetto V; Vasseur F; Zavala F; Schneider E; Ezine S
J Leukoc Biol; 2005 Nov; 78(5):1106-17. PubMed ID: 16266974
[TBL] [Abstract][Full Text] [Related]
6. Fas/Fas ligand signaling during gestational T cell development.
Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
[TBL] [Abstract][Full Text] [Related]
7. Fas system-mediated apoptosis suppresses lymphopoiesis.
Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells.
Camacho IA; Singh N; Hegde VL; Nagarkatti M; Nagarkatti PS
J Immunol; 2005 Jul; 175(1):90-103. PubMed ID: 15972635
[TBL] [Abstract][Full Text] [Related]
9. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
10. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
Jenkins M; Keir M; McCune JM
J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
Rich RF; Cook WJ; Green WR
Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
[TBL] [Abstract][Full Text] [Related]
13. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
[TBL] [Abstract][Full Text] [Related]
14. Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.
Gienau M; Hartmann KU
Thymus; 1997; 24(4):279-86. PubMed ID: 9493289
[TBL] [Abstract][Full Text] [Related]
15. Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes.
Nohara K; Pan X; Tsukumo S; Hida A; Ito T; Nagai H; Inouye K; Motohashi H; Yamamoto M; Fujii-Kuriyama Y; Tohyama C
J Immunol; 2005 Mar; 174(5):2770-7. PubMed ID: 15728486
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand expression is restricted to nonlymphoid thymic components in situ.
French LE; Wilson A; Hahne M; Viard I; Tschopp J; MacDonald HR
J Immunol; 1997 Sep; 159(5):2196-202. PubMed ID: 9278307
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
Tamura A; Katsumata M; Greene MI; Yui K
Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
19. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
Fecho K; Bentley SA; Cohen PL
Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
[TBL] [Abstract][Full Text] [Related]
20. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
